Pko Investment Management Joint Stock CO Bristol Myers Squibb CO Transaction History

Pko Investment Management Joint Stock CO

$882 Billion
Q1 2025

A detailed history of Pko Investment Management Joint Stock CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pko Investment Management Joint Stock CO holds 12,000 shares of BMY stock, worth $549,720. This represents 0.08% of its overall portfolio holdings.

Number of Shares

12,000

Previous 16,000 25.0%

Holding current value

$549,720

Previous $905 Million 19.13%

% of portfolio

0.08%

Previous 0.11%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 18, 2025	SELL	$53.9 - $63.11 $215,600 - $252,440	-4,000 Reduced 25.0%	12,000 $732 Million
Q4 2024 Mar 13, 2025	BUY	$51.92 - $59.94 $830,720 - $959,040	16,000 New	16,000 $905 Million
Q3 2024 Mar 13, 2025	SELL	$39.66 - $51.75 $555,240 - $724,500	-14,000 Reduced 41.18%	20,000 $1.03 Billion
Q1 2024 Mar 13, 2025	SELL	$47.98 - $54.4 $451,059 - $511,414	-9,401 Reduced 31.98%	20,000 $1.09 Billion
Q4 2023 Mar 13, 2025	BUY	$48.48 - $57.85 $763,850 - $911,484	15,756 Added 86.36%	34,000 $1.74 Billion
Q2 2023 Mar 13, 2025	BUY	$63.71 - $70.74 $700,810 - $778,140	11,000 Added 47.83%	34,000 $2.17 Billion
Q1 2023 Mar 13, 2025	SELL	$65.71 - $74.53 $65,710 - $74,530	-1,000 Reduced 4.17%	23,000 $1.59 Billion
Q4 2022 Mar 13, 2025	BUY	$68.48 - $81.09 $68,480 - $81,090	1,000 Added 4.55%	23,000 $1.65 Billion
Q3 2022 Mar 13, 2025	BUY	$0.13 - $76.84 $780 - $461,040	6,000 Added 37.5%	22,000 $1.56 Billion
Q2 2022 Mar 13, 2025	SELL	$72.62 - $79.98 $72,620 - $79,980	-1,000 Reduced 4.0%	24,000 $1.85 Billion
Q1 2022 Mar 13, 2025	SELL	$61.48 - $73.72 $1.84 Million - $2.21 Million	-30,000 Reduced 54.55%	25,000 $1.83 Billion
Q4 2021 Mar 13, 2025	BUY	$53.63 - $62.52 $1.37 Million - $1.6 Million	25,599 Added 87.07%	55,000 $3.43 Billion
Q4 2020 Mar 13, 2025	BUY	$57.74 - $65.43 $773,773 - $876,827	13,401 Added 83.76%	29,401 $1.82 Billion
Q4 2019 Mar 13, 2025	BUY	$49.21 - $64.19 $549,035 - $716,167	11,157 Added 61.15%	29,401 $1.89 Billion
Q3 2019 Mar 13, 2025	BUY	$42.77 - $50.71 $95,975 - $113,793	2,244 Added 14.03%	18,244 $925 Million
Q3 2018 Mar 13, 2025	BUY	$55.19 - $62.25 $123,846 - $139,689	2,244 Added 14.03%	18,244 $1.13 Billion
Q2 2018 Mar 13, 2025	SELL	$50.53 - $62.98 $287,869 - $358,797	-5,697 Reduced 23.8%	18,244 $1.01 Billion
Q4 2017 Mar 13, 2025	BUY	$59.94 - $65.35 $176,463 - $192,390	2,944 Added 14.02%	23,941 $1.47 Billion
Q3 2017 Mar 13, 2025	BUY	$55.23 - $63.74 $434,494 - $501,442	7,867 Added 59.92%	20,997 $1.34 Billion
Q2 2017 Mar 13, 2025	BUY	N/A	7,651 Added 139.64%	13,130 $732 Million
Q1 2017 Mar 13, 2025	SELL	N/A	-10,521	5,479 $298 Million

Others Institutions Holding BMY

# of Institutions

2,800

Shares Held

1.59B

Call Options Held

25.8M

Put Options Held

23.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $97.4B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pko Investment Management Joint Stock CO, based on Form 13F filings with the SEC.

News

Stay updated on Pko Investment Management Joint Stock CO with notifications on news.

Account

Pko Investment Management Joint Stock CO Bristol Myers Squibb CO Transaction History